These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 15911936

  • 21. Pilot open-label study of nefazodone in panic disorder.
    Bystritsky A, Rosen R, Suri R, Vapnik T.
    Depress Anxiety; 1999; 10(3):137-9. PubMed ID: 10604088
    [Abstract] [Full Text] [Related]

  • 22. How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database.
    Baldwin DS, Stein DJ, Dolberg OT, Bandelow B.
    Hum Psychopharmacol; 2009 Jun; 24(4):269-75. PubMed ID: 19334042
    [Abstract] [Full Text] [Related]

  • 23. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
    Lee P, Shu L, Xu X, Wang CY, Lee MS, Liu CY, Hong JP, Ruschel S, Raskin J, Colman SA, Harrison GA.
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):295-307. PubMed ID: 17472599
    [Abstract] [Full Text] [Related]

  • 24. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
    Honig A, Kuyper AM, Schene AH, van Melle JP, de Jonge P, Tulner DM, Schins A, Crijns HJ, Kuijpers PM, Vossen H, Lousberg R, Ormel J, MIND-IT investigators.
    Psychosom Med; 2007 Jun; 69(7):606-13. PubMed ID: 17846258
    [Abstract] [Full Text] [Related]

  • 25. Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression.
    Vaccarino AL, Evans KR, Sills TL, Kalali AH.
    Depress Anxiety; 2008 Jun; 25(12):1006-13. PubMed ID: 18800370
    [Abstract] [Full Text] [Related]

  • 26. Comorbidity of depressive and anxiety disorders for older Americans in the national comorbidity survey-replication.
    King-Kallimanis B, Gum AM, Kohn R.
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):782-92. PubMed ID: 19700950
    [Abstract] [Full Text] [Related]

  • 27. A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study.
    Brown ES, Vigil L, Khan DA, Liggin JD, Carmody TJ, Rush AJ.
    Biol Psychiatry; 2005 Dec 01; 58(11):865-70. PubMed ID: 15993860
    [Abstract] [Full Text] [Related]

  • 28. Citalopram and suicidality in adult major depression and anxiety disorders.
    Pedersen AG.
    Nord J Psychiatry; 2006 Dec 01; 60(5):392-9. PubMed ID: 17038305
    [Abstract] [Full Text] [Related]

  • 29. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV, McElroy SL, Harnett-Sheehan K, Keck PE, Janavs J, Rogers J, Gonzalez R, Shivakumar G, Suppes T.
    J Affect Disord; 2009 Jun 01; 115(3):376-85. PubMed ID: 19042026
    [Abstract] [Full Text] [Related]

  • 30. St. John's wort and Kava in treating major depressive disorder with comorbid anxiety: a randomised double-blind placebo-controlled pilot trial.
    Sarris J, Kavanagh DJ, Deed G, Bone KM.
    Hum Psychopharmacol; 2009 Jan 01; 24(1):41-8. PubMed ID: 19090505
    [Abstract] [Full Text] [Related]

  • 31. Persistence of abnormal cortisol levels in elderly persons after recovery from major depression.
    Beluche I, Chaudieu I, Norton J, Carrière I, Boulenger JP, Ritchie K, Ancelin ML.
    J Psychiatr Res; 2009 May 01; 43(8):777-83. PubMed ID: 19054531
    [Abstract] [Full Text] [Related]

  • 32. Treatment of older adults with co-morbid personality disorder and depression: a dialectical behavior therapy approach.
    Lynch TR, Cheavens JS, Cukrowicz KC, Thorp SR, Bronner L, Beyer J.
    Int J Geriatr Psychiatry; 2007 Feb 01; 22(2):131-43. PubMed ID: 17096462
    [Abstract] [Full Text] [Related]

  • 33. Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression.
    Howland RH, Wilson MG, Kornstein SG, Clayton AH, Trivedi MH, Wohlreich MM, Fava M.
    Ann Clin Psychiatry; 2008 Feb 01; 20(4):209-18. PubMed ID: 19034753
    [Abstract] [Full Text] [Related]

  • 34. Depressive symptoms and intellectual functioning in anxiety patients treated with clorazepate.
    Fabre LF, Putman HP.
    J Clin Psychiatry; 1988 May 01; 49(5):189-92. PubMed ID: 2896666
    [Abstract] [Full Text] [Related]

  • 35. Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial.
    Kok RM, Nolen WA, Heeren TJ.
    Int J Geriatr Psychiatry; 2007 Dec 01; 22(12):1247-54. PubMed ID: 17562523
    [Abstract] [Full Text] [Related]

  • 36. A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults.
    Castaneda AE, Tuulio-Henriksson A, Marttunen M, Suvisaari J, Lönnqvist J.
    J Affect Disord; 2008 Feb 01; 106(1-2):1-27. PubMed ID: 17707915
    [Abstract] [Full Text] [Related]

  • 37. Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder.
    Amsterdam JD, Shults J, Rutherford N.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan 01; 32(1):100-6. PubMed ID: 17804135
    [Abstract] [Full Text] [Related]

  • 38. Suicidal ideation and anxiety disorders: elevated risk or artifact of comorbid depression?
    Norton PJ, Temple SR, Pettit JW.
    J Behav Ther Exp Psychiatry; 2008 Dec 01; 39(4):515-25. PubMed ID: 18294614
    [Abstract] [Full Text] [Related]

  • 39. Comorbid depression and anxiety in later life: patterns of association, subjective well-being, and impairment.
    Cairney J, Corna LM, Veldhuizen S, Herrmann N, Streiner DL.
    Am J Geriatr Psychiatry; 2008 Mar 01; 16(3):201-8. PubMed ID: 18310551
    [Abstract] [Full Text] [Related]

  • 40. Cost savings with nefazodone in treating depression.
    Hales RE, Hilty DM, Brunson GH.
    J Clin Psychiatry; 2002 Mar 01; 63 Suppl 1():48-51. PubMed ID: 11890565
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.